ICD-10

ICD-10 code P02

You are here: Home > ICD-10-CM > P00-P96 > P00-P04

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- P00-P96
Certain conditions originating in the perinatal period
- P00-P04
Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery

P02

Newborn (suspected to be) affected by complications of placenta, cord and membranes

ICD-10 code P02 for Newborn (suspected to be) affected by complications of placenta, cord and membranes

Code first any current condition in newborn
P02.0
Newborn (suspected to be) affected by placenta previa
P02.1
Newborn (suspected to be) affected by other forms of placental separation and hemorrhage
P02.2
Newborn (suspected to be) affected by other and unspecified morphological and functional abnormalities of placenta
P02.3
Newborn (suspected to be) affected by placental transfusion syndromes
P02.4
Newborn (suspected to be) affected by prolapsed cord
P02.5
Newborn (suspected to be) affected by other compression of umbilical cord
P02.6
Newborn (suspected to be) affected by other and unspecified conditions of umbilical cord
P02.7
Newborn (suspected to be) affected by chorioamnionitis
P02.8
Newborn (suspected to be) affected by other abnormalities of membranes
P02.9
Newborn (suspected to be) affected by abnormality of membranes, unspecified
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us